Paper30078747
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
Kahles A and 10 others. Cancer Cell, 2018. Cited by 768 papers, by iCite.
Cite this record
ConductScience Library. Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients. Papers, record 30078747. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30078747
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alternative Splicing | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Polymorphism, Single Nucleotide | |
| Quantitative Trait Loci | |
| Sequence Analysis, RNA | |
| Exome Sequencing |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 CA235162 | NCI NIH HHS | United States | R01CA235162 | PubMed | NIH RePORTER |
| R01 NS117666 | NINDS NIH HHS | United States | R01NS117666 | PubMed | NIH RePORTER |
| R01 NS096236 | NINDS NIH HHS | United States | R01NS096236 | PubMed | NIH RePORTER |
| K08 NS045077 | NINDS NIH HHS | United States | K08NS045077 | PubMed and NIH | NIH RePORTER |
| R01 NS081125 | NINDS NIH HHS | United States | R01NS081125 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT06315868 | Breast Cancer Subtype Characterization Through Patient's Derived Organoids. | Background |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 30107172 | Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens. | https://conductscience.org/library/papers/30107172 |
Source PubMed
References72
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29596782 | Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines. | Cell Syst | 2018 | https://conductscience.org/library/papers/29596782 | PubMed |
| 2 | 27251275 | Proteogenomics connects somatic mutations to signalling in breast cancer. | Nature | 2016 | https://conductscience.org/library/papers/27251275 | PubMed |
| 3 | 29222161 | Detection of Proteome Diversity Resulted from Alternative Splicing is Limited by Trypsin Cleavage Specificity. | Mol Cell Proteomics | 2018 | https://conductscience.org/library/papers/29222161 | PubMed |
| 4 | 27372738 | Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer. | Cell | 2016 | https://conductscience.org/library/papers/27372738 | PubMed |
| 5 | 29022597 | Genetic effects on gene expression across human tissues. | Nature | 2017 | https://conductscience.org/library/papers/29022597 | PubMed |
| 6 | 16787944 | The connection between splicing and cancer. | J Cell Sci | 2006 | https://conductscience.org/library/papers/16787944 | PubMed |
| 7 | 25873244 | The CPTAC Data Portal: A Resource for Cancer Proteomics Research. | J Proteome Res | 2015 | https://conductscience.org/library/papers/25873244 | PubMed |
| 8 | 19228619 | IDH1 and IDH2 mutations in gliomas. | N Engl J Med | 2009 | https://conductscience.org/library/papers/19228619 | PubMed |
| 9 | 28038678 | Human splicing diversity and the extent of unannotated splice junctions across human RNA-seq samples on the Sequence Read Archive. | Genome Biol | 2016 | https://conductscience.org/library/papers/28038678 | PubMed |
| 10 | 17344846 | Patterns of somatic mutation in human cancer genomes. | Nature | 2007 | https://conductscience.org/library/papers/17344846 | PubMed |
| 11 | 25109877 | Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin. | Cell | 2014 | https://conductscience.org/library/papers/25109877 | PubMed |
| 12 | 24498085 | A pan-cancer analysis of transcriptome changes associated with somatic mutations in U2AF1 reveals commonly altered splicing events. | PLoS One | 2014 | https://conductscience.org/library/papers/24498085 | PubMed |
| 13 | 23861464 | SF3B1 mutations are associated with alternative splicing in uveal melanoma. | Cancer Discov | 2013 | https://conductscience.org/library/papers/23861464 | PubMed |
| 14 | 26842708 | Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage. | Nat Commun | 2016 | https://conductscience.org/library/papers/26842708 | PubMed |
| 15 | 20133837 | The alternative splicing repressors hnRNP A1/A2 and PTB influence pyruvate kinase isoform expression and cell metabolism. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20133837 | PubMed |
| 16 | 29316429 | Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29316429 | PubMed |
| 17 | 23374354 | Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. | Cell | 2013 | https://conductscience.org/library/papers/23374354 | PubMed |
| 18 | 20644199 | The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. | Genome Res | 2010 | https://conductscience.org/library/papers/20644199 | PubMed |
| 19 | 28717182 | Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. | Sci Rep | 2017 | https://conductscience.org/library/papers/28717182 | PubMed |
| 20 | 28898209 | Neoantigen prediction and the need for validation. | Nat Biotechnol | 2017 | https://conductscience.org/library/papers/28898209 | PubMed |
Cited by620
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 768 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42959665 | Nanoimaging, Spectroscopy, and Biosensor Assays for Alternatively Spliced RNA Isoforms in Disease Diagnostics. | ACS Omega | 2026 | https://conductscience.org/library/papers/42959665 | PubMed |
| 42951964 | T and B cells recognize splicing-derived neutrophil neoantigens in lupus. | Nature | 2026 | https://conductscience.org/library/papers/42951964 | PubMed |
| 42940202 | Normal-Tissue Absence, Rather Than Cross-Patient Prevalence, Limits a Fixed Splice-Junction Panel in Hepatocellular Carcinoma: From a Pre-Specified In Silico Screen to a Genome-Wide Analysis. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940202 | PubMed |
| 42843924 | TCASIA: an integrative atlas linking alternative splicing landscapes for cancer immunotherapy. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/42843924 | PubMed |
| 42819770 | mRNA processing in cancer immunotherapy: emerging targets, resistance mechanisms, and therapeutic opportunities. | Front Immunol | 2026 | https://conductscience.org/library/papers/42819770 | PubMed |
| 42798884 | Personalised neoantigen vaccines for precision oncology in Southeast Asia: clinical opportunities, infrastructure challenges, and policy perspectives. | Front Immunol | 2026 | https://conductscience.org/library/papers/42798884 | PubMed |
| 42798475 | Acidosis promotes exon skipping through sequestering SR-rich splicing factors in nuclear speckles. | Front Mol Biosci | 2026 | https://conductscience.org/library/papers/42798475 | PubMed |
| 42792926 | Genome-Wide Analysis of Alternative Splicing Identifies a Prognostic Signature in ER-Positive Breast Cancer. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42792926 | PubMed |
| 42792878 | Alternative RNA Splicing in Cancer: Molecular Mechanisms, Functional Consequences, Biomarkers and Therapeutic Opportunities. | Genes (Basel) | 2026 | https://conductscience.org/library/papers/42792878 | PubMed |
| 42751865 | SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA-PKcs/CHK1 replicative checkpoint to inhibit cell growth in non-small cell lung cancer. | Mol Oncol | 2026 | https://conductscience.org/library/papers/42751865 | PubMed |
| 42750313 | RBM25 Drives Hepatocellular Carcinoma Progression by Stabilizing YAP Through Regulating Oncogenic Splicing-switch of MYPT1. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42750313 | PubMed |
| 42744865 | Viral mimicry escape as a necessary feature of malignant transformation. | Nat Rev Cancer | 2026 | https://conductscience.org/library/papers/42744865 | PubMed |
| 42702621 | Benchmarking RNA-seq with the Quartet and MAQC reference materials to establish best practices for accurate alternative splicing analysis. | Nat Commun | 2026 | https://conductscience.org/library/papers/42702621 | PubMed |
| 42680560 | Long-read sequencing reveals widespread novel splicing and neojunction-derived neoantigens in nasopharyngeal carcinoma. | Genome Res | 2026 | https://conductscience.org/library/papers/42680560 | PubMed |
| 42657538 | Dark matter matters: from noncoding RNA regulation to cancer immunity. | Oncoimmunology | 2026 | https://conductscience.org/library/papers/42657538 | PubMed |
| 42639267 | RNA-Binding Proteins: Function, Biological Mechanisms, and Therapeutic Opportunities. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42639267 | PubMed |
| 42599699 | Splicing genes as main targets of differential splicing. | G3 (Bethesda) | 2026 | https://conductscience.org/library/papers/42599699 | PubMed |
| 42567927 | Charting intratumor heterogeneity from bench to bedside. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42567927 | PubMed |
| 42534181 | Harnessing Tumor-Specific Transcript Diversity Uncovers a Shared Neoantigen Reservoir for Pancreatic Ductal Adenocarcinoma. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42534181 | PubMed |
| 42465751 | Non-canonical and induced neoantigens as emerging sources of cancer-specific immunotherapy targets. | Front Immunol | 2026 | https://conductscience.org/library/papers/42465751 | PubMed |
Genes23
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30078747
GET https://conductscience.org/api/papers/v1/30078747/references?page=2